drugset / Trial / NCT06071143
Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease
NaSingle-groupOpen-labelTreatment
Summary
A Single arm, Open-labelled, Dose-escalation, Single-center, Phase 1 Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Autologous Urine-derived Stem Cells, 『KDSTEM Inj.』, in Patients with Chronic Kidney Disease. The aim of this study is to evaluate the safety and preliminary efficacy of KDSTEM Inj. in the treatment in Patients with Chronic Kidney Disease.
Timeline
- Start
- 2024-02-29
- Primary completion
- 2026-03-09
- Completion
- 2026-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KDSTEM Inj. | Cell therapy | 1e+08 cells | Intravenous |
| Subject | KDSTEM Inj. | Cell therapy | 3e+08 cells | Intravenous |